The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Open accessAbstract
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lineage C betacoronavirus that since its emergence in 2012 has caused outbreaks in human populations with case-fatality rates of ∼36%. As in other coronaviruses, the spike (S) glycoprotein of MERS-CoV mediates receptor recognition and membrane fusion and is the primary target of the humoral immune response during infection. Here we use structure-based design to develop a generalizable strategy for retaining coronavirus S proteins in the antigenically optimal prefusion conformation and demonstrate that our engineered immunogen is able to elicit high neutralizing antibody titers against MERS-CoV. We also determined high-resolution structures of the trimeric MERS-CoV S ectodomain in complex with G4, a stem-directed neutralizing antibody. The structures reveal that G4 recognizes a glycosylated loop that is variable among coronaviruses and they define four conformational states of the trimer wherein each receptor-binding domain is either tightly packed at the membrane-distal apex or rotated into a receptor-accessible conformation. Our studies suggest a potential mechanism for fusion initiation through sequential receptor-binding events and provide a foundation for the structure-based design of coronavirus vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Immune responses are improved by introducing two consecutive proline residues (2P), which are known to retain the full-length S protein in the prefusion conformation.64,65”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [64]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both vaccines encode the same full-length, pre-fusion stabilized severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein13,14 and are encapsulated in lipid nanoparticles (LNPs) with identical composition.”
From Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine (2022) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Stabilizing coronavirus spike proteins by substituting two prolines at the top of heptad repeat 1 prevents structural rearrangements of the fusion (S2) subunit.”
From An mRNA Vaccine against SARS-CoV-2 — Preliminary Report (2020) · cites this paper as [27]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, S-2P conformational stability translates into greater immunogenicity,27-29 based on preservation of neutralization-sensitive epitopes at the apex of the prefusion molecule, as shown for respiratory syncytial virus F glycoprotein,30 and improved protein expression,27 which is particularly advantageous for gene-based antigen delivery.”
From An mRNA Vaccine against SARS-CoV-2 — Preliminary Report (2020) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 46,047
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
Scheres, S. H. W. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.09.006 · Cited by 5,446
How good are my data and what is the resolution?
Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,743
Comparative Protein Structure Modeling Using MODELLER
Webb, B., & Šali, A. (2016) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.3 · Cited by 4,404
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Ashkenazy, H., Abadi, S., Martz, E., Chay, O., Mayrose, I., Pupko, T., & Ben-Tal, N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw408 · Cited by 3,163
Cited by
Sorted by citations
Items 701–800 of 1,000
Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants
Zhang, J., Xia, Y., Liu, X., & Liu, G. (2023) · Bioengineering · doi:10.3390/bioengineering10020148 · Cited by 8
Deshpande, A. A., Schormann, N., Piepenbrink, M. S., Martínez‐Sobrido, L., Kobie, J. J., & Walter, M. R. (2023) · FEBS Journal · doi:10.1111/febs.16777 · Cited by 8
The status of COVID-19 vaccines in India: A review
Jha, D. K., Pranay, K., Samiksha, Kumar, A., & Yashvardhini, N. (2023) · Vacunas (English Edition) · doi:10.1016/j.vacun.2023.04.003 · Cited by 12
Identification of Evolutionary Trajectories Shared across Human Betacoronaviruses
Escalera‐Zamudio, M., Pond, S. L. K., de la Viña, N. M., Gutiérrez, B., Inward, R. P. D., Thézé, J., van Dorp, L., Castelán-Sánchez, H. G., Bowden, T. A., Pybus, O. G., et al. (2023) · Genome Biology and Evolution · doi:10.1093/gbe/evad076 · Cited by 6
A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activitiesPreprint
Yin, D., Ling, S., Tian, X., Li, Y., Xu, Z., Jiang, H., Zhang, X., Wang, X., Shi, Y., Zhang, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.14.093054 · Cited by 8
Shiakolas, A. R., Kramer, K. J., Wrapp, D., Richardson, S., Schäfer, A., Wall, S. J., Wang, N.-S., Janowska, K., Pilewski, K. A., Venkat, R., et al. (2020) · bioRxiv · doi:10.1101/2020.12.20.414748 · Cited by 5
Self-citationStar-shaped Triazine-derivatives: would they crossbind SARS-CoV-2 spike helices?Preprint
Coll, J. M. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-xb6sx-v2 · Cited by 8
Dosey, A. M., Ellis, D., Boyoglu-Barnum, S., Syeda, H., Saunders, M., Watson, M., Kraft, J. C., Pham, M. N., Guttman, M., Lee, K. K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.23.541996 · Cited by 8
Proscan: a structure-based proline design web server
Felbinger, N. R., Filho, H. V. R., & Pierce, B. G. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae408 · Cited by 7
Grewe, I., Friedrich, M., Dieck, M.-L., Spohn, M., Ly, M. L., Krähling, V., Mayer, L., Mellinghoff, S. C., Rottstegge, M., Kraemer, R., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1500615 · Cited by 7
Renner, T. M., Stuible, M., Rossotti, M. A., Rohani, N., Donates, Y. C., Sauvageau, J., Deschatelets, L., Dudani, R., Harrison, B. A., Baardsnes, J., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00830-w · Cited by 7
Potent neutralization of Marburg virus by a vaccine-elicited antibody
Addetia, A., Perruzza, L., Sprouse, K. R., Park, Y., McCallum, M., Stewart, C., Partini, B., Brown, J. T., Donati, A., Culap, K., et al. (2025) · Nature · doi:10.1038/s41586-025-09868-1 · Cited by 7
Ye, W., Dang, Y., Wang, Y., Yang, Q., Zhang, H., Ye, C., Wei, J., Pei, J., Pei, X., Jiang, D., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70285-7 · Cited by 7
Glycan Nanostructures of Human Coronaviruses
Guo, W., Lakshminarayanan, H., Rodriguez‐Palacios, A., Salata, R. A., Xu, K., & Draz, M. S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s302516 · Cited by 7
SARS-CoV-2 S Glycoprotein Stabilization Strategies
Pedenko, B., Sulbarán, G., Guilligay, D., Effantin, G., & Weissenhorn, W. (2023) · Viruses · doi:10.3390/v15020558 · Cited by 8
Sepotokele, K. M., O’Kennedy, M. M., Hayes, M. C., Wandrag, D. B. R., Smith, P., & Abolnik, C. (2023) · Poultry Science · doi:10.1016/j.psj.2023.102953 · Cited by 7
Lessons learned from urgent computing in Europe: Tackling the COVID-19 pandemic
López, N., Debbio, L. D., Baaden, M., Praprotnik, M., Grigori, L., Simões, C., Bogaerts, S., Berberich, F., Lippert, T., Ignatius, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024891118 · Cited by 7
Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes
Hein, S., Benz, N. I., Eisert, J., Herrlein, M., Oberle, D., Dreher, M., Stingl, J., Hildt, C., & Hildt, E. (2021) · Vaccines · doi:10.3390/vaccines9121419 · Cited by 7
What the Moderna–NIH COVID vaccine patent fight means for research
Ledford, H. K. (2021) · Nature · doi:10.1038/d41586-021-03535-x · Cited by 7
Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice
Paschall, A. V., Ozdilek, A., Briner, S. L., Brindley, M. A., & Avci, F. Y. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.12.058 · Cited by 7
Yang, M.-C., Wang, C.-C., Tang, W.-C., Chen, K.-M., Chen, C., Lin, H., Hsieh, Y., Wang, N.-H., Kuo, Y.-C., Chu, P.-T., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283473 · Cited by 8
Self-citationProgress in vaccine development for infectious diseases—a Keystone Symposia report
Cable, J., Graham, B. S., Koup, R. A., Seder, R. A., Karikó, K., Pardi, N., Barouch, D. H., Sharma, B., Rauch, S., Nachbagauer, R., et al. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14975 · Cited by 8
Self-citationLSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters
de Moor, W. R. J., Williamson, A., Schäfer, G., Douglass, N., Gers, S., Sutherland, A. D., Blumenthal, M. J., Margolin, E., Shaw, M. L., Preiser, W., et al. (2023) · Viruses · doi:10.3390/v15071409 · Cited by 7
Stiving, A. Q., Foreman, D. J., VanAernum, Z. L., Dürr, E., Wang, S., Vlasak, J., Galli, J. D., Kafader, J. O., Tsukidate, T., Li, X., et al. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.3c00309 · Cited by 8
On the irrationality of rational design of an HIV vaccine in light of protein intrinsic disorder
Uversky, V. N. (2021) · Archives of Virology · doi:10.1007/s00705-021-04984-5 · Cited by 7
“Just in Time”: The Role of Cryo-Electron Microscopy in Combating Recent Pandemics
Frank, J. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00318 · Cited by 7
Modified mRNA-Based Vaccines Against Coronavirus Disease 2019
Wang, A. Y. L. (2022) · Cell Transplantation · doi:10.1177/09636897221090259 · Cited by 7
HIV infection and the implication for COVID‐19 vaccination
Oyelade, T., Raya, R. P., & Latief, K. (2022) · Public Health Challenges · doi:10.1002/puh2.14 · Cited by 6
Newly-onset Autoimmune Diabetes Mellitus Triggered by COVID 19 Infection: A Case-based Review
Akkuş, G. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/2666145415666221004111511 · Cited by 7
Closing coronavirus spike glycoproteins by structure-guided designPreprint
McCallum, M., Walls, A. C., Corti, D., & Veesler, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.03.129817 · Cited by 7
The N-glycosylation sites and Glycan-binding ability of S-protein in SARS-CoV-2 CoronavirusPreprint
Chen, W., Hui, Z., Ren, X., Luo, Y., Shu, J. H., Yu, H., & Li, Z. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.01.406025 · Cited by 7
Differential Dynamic Behavior of Prefusion Spike Proteins of SARS Coronaviruses 1 and 2Preprint
Kumar, V. G., Ogden, D. S., Isu, U. H., Polasa, A., Losey, J., & Moradi, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.25.424008 · Cited by 7
Progress in research on the S protein as the target of COVID-19 vaccines
Abdalla, M., El‐Arabey, A. A., & Jiang, X. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1918003 · Cited by 7
Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responsesPreprint
Walls, A. C., Sprouse, K. R., Joshi, A., Bowen, J. E., Franko, N., Navarro, M. J., Stewart, C., McCallum, M., Goecker, E. A., Degli-Angeli, E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.08.471707 · Cited by 8
Wadapurkar, R., Singh, S., & Singh, A. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.01.087 · Cited by 6
Innovations in vaccine design: Computational tools and techniques
Nag, R., Srivastava, S., Rizvi, S., Ahmed, S., & Raza, S. T. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.01.015 · Cited by 7
Wang, S., Qin, M., Xu, L., Mu, T., Zhao, P., Sun, B., Wu, Y., Song, L., Wu, H., Wang, W., et al. (2023) · Vaccines · doi:10.3390/vaccines11091427 · Cited by 6
Morshed, M. N., Karim, M. R., Akter, R., Iqbal, S., Mathiyalagan, R., Ahn, J. C., Yang, D., Song, J. H., Yang, D. U., & Yang, D. U. (2024) · Medical Science Monitor · doi:10.12659/msm.942899 · Cited by 7
Zhu, J., Wang, Z., Li, Y., Zhang, Z., Ren, S., Wang, J., Xie, S., Liao, Z., Song, B., Wu, W., et al. (2024) · Journal of Virology · doi:10.1128/jvi.00521-24 · Cited by 6
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env–ferritin nanoparticle designs
Mu, Z., Whitley, J., Martik, D., Sutherland, L. L., Newman, A., Barr, M., Parks, R., Wiehe, K. J., Cain, D. W., Hodges, K. Z., et al. (2024) · Journal of Virology · doi:10.1128/jvi.00137-24 · Cited by 6
Ma, S., Zhang, D., Wang, Q., Zhu, L., Wu, X., Ye, S., & Wang, Y. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012438 · Cited by 6
CD81 fusion alters SARS-CoV-2 Spike trafficking
Cone, A. S., Zhou, Y., McNamara, R. P., Eason, A. B., Arias, G. F., Landis, J. T., Shifflett, K., Chambers, M. G., Yuan, R., Willcox, S., et al. (2024) · mBio · doi:10.1128/mbio.01922-24 · Cited by 6
Yoo, R., Jore, M. M., & Julien, J. (2025) · Immunological Reviews · doi:10.1111/imr.70001 · Cited by 6
Powell, A. E., Caruso, H., Park, S., Chen, J., O’Rear, J., Ferrer, B., Stieh, D. J., Weiss, A. M., Belnap, D. M., Walker, A. E., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68458-5 · Cited by 6
Immunogenicity of Different Forms of Middle East Respiratory Syndrome S Glycoprotein
Ozharovskaia, T. A., Zubkova, O. V., Dolzhikova, I. V., Gromova, A. S., Grousova, D. M., Ильдарович, Т. А., Popova, O. D., Shcheblyakov, D. V., Scherbinin, D. N., Dzharullaeva, A. S., et al. (2019) · Acta Naturae · doi:10.32607/20758251-2019-11-1-38-47 · Cited by 6
Conserved High Free Energy Sites in Human Coronavirus Spike Glycoprotein Backbones
Penner, R. (2020) · Journal of Computational Biology · doi:10.1089/cmb.2020.0193 · Cited by 6
Functional profiling of Covid 19 vaccine candidate by flow virometry
Prout, A., Rustandi, R. R., Tubbs, C. M., Winters, M. A., McKenna, P. M., & Vlasak, J. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.08.006 · Cited by 7
Prevalence and mechanisms of evolutionary contingency in human influenza H3N2 neuraminidase
Lei, R., Tan, T. J. C., Garcia, A. H., Wang, Y., Diefenbacher, M. V., Teo, C., Gopan, G., Dargani, Z. T., Teo, Q. W., Graham, C. S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34060-8 · Cited by 6
Wang, S., Xu, L., Mu, T., Qin, M., Zhao, P., Xie, L., Du, L., Wu, Y., Legrand, N., Mouchain, K., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.979641 · Cited by 7
Sarma, K., Bali, N. K., Sarmah, N., & Borkakoty, B. (2022) · COVID · doi:10.3390/covid2120124 · Cited by 6
Zhang, T., Zheng, N., Wang, Z., & Xu, X. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2174755 · Cited by 6
A CTB-SARS-CoV-2-ACE-2 RBD Mucosal Vaccine Protects Against Coronavirus Infection
Denes, B. S., Fuller, R. N., Kelin, W., Levin, T., Gil, J., Harewood, A., Lőrincz, M., Wall, N. R., Firek, A. F., & Langridge, W. H. R. (2023) · Vaccines · doi:10.3390/vaccines11121865 · Cited by 6
Tiruthani, K., Cruz-Teran, C. A., Chan, J. F., Ma, A. L., McSweeney, M. D., Wolf, W., Yuan, S., Poon, V. K., Chan, C. C. S., Botta, L., et al. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10650 · Cited by 7
Kwong, P. D. (2020) · Data Archiving and Networked Services (DANS) · doi:10.17632/y2j4k2mkd6 · Cited by 6
Xiao, Y., Xu, H., Guo, W. Q., Zhao, Y., Luo, Y., Wang, M., He, Z., Ding, Z., Liu, J., Deng, L., et al. (2020) · Molecular Biomedicine · doi:10.1186/s43556-020-00017-w · Cited by 6
Andryukov, B. G., & Lyapun, I. N. (2020) · Russian Clinical Laboratory Diagnostics · doi:10.18821/0869-2084-2020-65-12-757-766 · Cited by 6
Synthetic proteins for COVID-19 diagnostics
Schein, C. H., Levine, C. B., McLellan, S., Negi, S. S., Braun, W. A., Dreskin, S. C., Anaya, E. S., & Schmidt, J. G. (2021) · Peptides · doi:10.1016/j.peptides.2021.170583 · Cited by 6
Rey, F. A. (2021) · Comptes Rendus Biologies · doi:10.5802/crbiol.53 · Cited by 11
Jang, T., Park, W.-J., Lee, H., Woo, H., Lee, S., Kim, K.-C., Kim, S. S., Hong, E., Song, J., & Lee, J.-Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-05318-4 · Cited by 5
Huang, Y.-L., Huang, S.-W., Shen, C., Cheng, D., & Wang, J. (2022) · Viruses · doi:10.3390/v14020364 · Cited by 6
Ma, M., Xia, B., Wang, Z., Hao, Y., Zhang, T., & Xu, X. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1073892 · Cited by 6
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spikePreprint
Tan, T. J. C., Mou, Z., Lei, R., Ouyang, W. O., Yuan, M., Song, G., Andrabi, R., Wilson, I. A., Kieffer, C., Dai, X., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.24.509341 · Cited by 6
Zhang, S., Xu, C.-L., Wang, J., Xiong, X., & Wang, J. (2025) · Journal of Virology · doi:10.1128/jvi.00078-25 · Cited by 5
Stabilization of norovirus GII.3 virus-like particles by rational disulfide engineering
Warren, C., Galli, J. D., Bystol, K., O’Donnell, G. T., Swartz, A. R., Dewar, E. A., Fulton, C. M., Shen, P., Gonzalez-Fernandez, E., DeWitt, L. A., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01254-2 · Cited by 5
Abiona, O. M., Wang, N., Leist, S. R., Schäfer, A., Cockrell, A. S., Wang, L., Bangaru, S., Stevens, L. J., Graham, R. L., Kocher, J., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111632 · Cited by 5
Self-citationThe Input of Structural Vaccinology in the Search for Vaccines against Bunyaviruses
Serris, A. (2021) · Viruses · doi:10.3390/v13091766 · Cited by 5
Lorbetskie, B., White, T., Creskey, M., Zhang, X., Girard, M., Tam, R. Y., Sauvé, S., & Lu, H. (2022) · Journal of Chromatography A · doi:10.1016/j.chroma.2022.463424 · Cited by 5
Babaeimarzangou, S. S., Zaker, H., Soleimannezhadbari, E., Shamsi-Gamchi, N., Kazeminia, M., Tarighi, S., Seyedian, H., Tsatsakis, A. M., Spandidos, D. A., & Margina, D. M. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11741 · Cited by 5
PF-D-Trimer, a protective SARS-CoV-2 subunit vaccine: immunogenicity and application
Zhang, Z., Zhou, J., Ni, P., Hu, B., Jolicoeur, N., Deng, S., Xiao, Q., He, Q., Li, G., Xia, Y. Z., et al. (2023) · npj Vaccines · doi:10.1038/s41541-023-00636-8 · Cited by 4
Stuible, M., Schrag, J. D., Sheff, J. G., Zoubchenok, D., Lord‐Dufour, S., Cass, B., L’Abbé, D., Pelletier, A., Rossotti, M. A., Tanha, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-43661-2 · Cited by 6
Bruch, E. M., Zhu, S., Szymkowicz, L., Blake, T., Kiss, T., James, D. A., Rak, A., Narayan, K., Balmer, M. T., & Chicz, R. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-52499-1 · Cited by 7
S–6P exhibits better immunogenicity than S–2P at lower doses of COVID-19 mRNA vaccines
Zhu, Z., Zhang, L., Li, S., Gao, Y., Wang, Y., Ma, X., Chen, Z., Wu, S., Zhang, Y., Zhang, M., et al. (2024) · Decoding Infection and Transmission · doi:10.1016/j.dcit.2024.100017 · Cited by 5
Insights into structural vaccinology harnessed for universal coronavirus vaccine development
Lim, C. P., Leow, C. Y., Lim, H. T., Kok, B. H., Chuah, C., Oliveira, J. I. N., Jones, M. K., & Leow, C. Y. (2024) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2024.13.3.202 · Cited by 6
Sequence of the SARS-CoV-2 Spike Transmembrane Domain Encodes Conformational Dynamics
Lall, S., Balaram, P., Mathew, M. K., & Gosavi, S. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c05270 · Cited by 5
Progress in the Development of Structure-Based Vaccines
Thomas, S., & Abraham, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1892-9_2 · Cited by 5
Meng, K., Zhang, Y., Liu, Q., Huyan, Y., Zhu, W., Xiang, Y., & Meng, G. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.802098 · Cited by 5
Haverkamp, A.-K., Bosch, B., Spitzbarth, I., Lehmbecker, A., Te, N., Bensaïd, A., Segalés, J., & Baumgärtner, W. (2019) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2019.109939 · Cited by 5
Lan, Q., Xia, S., & Lu, L. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-8702-0_7 · Cited by 5
Hassan, A. O., Kafai, N. M., Dmitriev, I., Fox, J., Smith, B. K., Harvey, I. B., Chen, R. E., Winkler, E. S., Wessel, A. W., Case, J., et al. (2020) · bioRxiv · doi:10.1101/2020.07.16.205088 · Cited by 6
Liu, X., Song, H., Jiang, J., Gao, X., Yi, Y., Shang, Y., Li, J., Li, D., Zeng, Z., Li, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.05.428685 · Cited by 5
A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivoPreprint
Hanke, L., Das, H., Sheward, D. J., Vidakovics, L. P., Urgard, E., Moliner-Morro, A., Kim, C., Karl, V., Pankow, A. P., Smith, N. L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.20.436243 · Cited by 5
Rappaport, A., Hong, S., Scallan, C. D., Gitlin, L., Akoopie, A., Boucher, G. R., Egorova, M., Espinosa, J. A., Fidanza, M., Kachura, M. A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.08.467773 · Cited by 5
Moliva, J. I., Andrew, S. F., Flynn, B. J., Wagner, D. A., Foulds, K. E., Gagné, M., Flebbe, D. R., Lamb, E., Provost, S. J., Marquez, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.22.567930 · Cited by 5
Malewana, G. B. R., Stalls, V., May, A. J., Lu, X., Martinez, D. R., Schäfer, A., Li, D., Barr, M., Sutherland, L. L., Lee, E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.18.572191 · Cited by 5
Advances in the structure-based design of protein vaccines for respiratory infectious diseases
Tie, X., Li, J., Wu, H., Weng, R., Zhang, Y., Li, J., & Chen, K. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.10.008 · Cited by 5
Fight fire with fire: the need for a vaccine based on intrinsic disorder and structural flexibility
Uversky, V. N. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00079 · Cited by 4
Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2
Liu, J., Han, H., Yang, B., Zhang, N., Li, J., Chen, X., Wu, J., Zhao, Y., & Yang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1416375 · Cited by 4
Malewana, G. B. R., Stalls, V., May, A. J., Lu, X., Martinez, D. R., Schäfer, A., Li, D., Barr, M., Sutherland, L. L., Lee, E., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adn5651 · Cited by 10
Dey, S., Pahari, P., Shukla, M., Andrabi, R., & Das, D. K. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115916 · Cited by 4
Zhou, H., Sun, Y., Zhang, L., Liang, X., Bai, J., Gao, Y., & Jiang, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149888 · Cited by 4
TMPRSS2-mediated coronavirus spike activation and inhibition
McCallum, M., Case, J. B., Brown, J. T., Park, Y., Lee, J., Sutherland, E., Aggarwal, A., Gibson, C. A., Lempp, F. A., Stewart, C., et al. (2026) · Nature Structural & Molecular Biology · doi:10.1038/s41594-026-01801-y · Cited by 5
Plant lectins as versatile tools to fight coronavirus outbreaks
Simplicien, M., Pério, P., Sudor, J., Barre, A., Benoist, H., Damme, E. J. M. V., & Rougé, P. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10094-4 · Cited by 4
Kachko, A. V., Selvaraj, P., Liu, S., Kim, J., Rotstein, D. S., Stauft, C. B., Chabot, S., Rajasagi, N. K., Zhao, Y., Wang, T. T., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.12.052 · Cited by 4
Ahuja, R., Vishwakarma, P., Raj, S., Kumar, V., Khatri, R., Lohiya, B., Saxena, S., Kaur, G., Singh, G., Asthana, S., et al. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2351664 · Cited by 4
Peters, M. H. (2024) · Viruses · doi:10.3390/v16060912 · Cited by 4
Development and application of an uncapped mRNA platform
Zheng, X., Liu, B., Ni, P., Cai, L., Shi, X., Ke, Z., Zhang, S., Hu, B., Yang, B., Xu, Y., et al. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2437046 · Cited by 5
COVID-19 variants that escape vaccine immunity: Global and Indian context—are more vaccines needed?
Deb, B., Vilvadrinath, R., & Goel, S. (2021) · Journal of Biosciences · doi:10.1007/s12038-021-00226-7 · Cited by 5
Lee, J. K., & Shin, O. S. (2022) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2021.01669 · Cited by 4
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes
Villarraza, J., Fuselli, A., Gugliotta, A., Garay, E., Rodríguez, M. C., Fontana, D., Antuña, S., Gastaldi, V., Battagliotti, J. M., Tardivo, M. B., et al. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12520-5 · Cited by 4
Design, structure and plasma binding of ancestral β-CoV scaffold antigens
Hueting, D., Schriever, K., Sun, R., Vlachiotis, S., Zuo, F., Du, L., Persson, H., Hofström, C., Ohlin, M., Wallden, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42200-x · Cited by 4
Metadata
- Authors
- Pallesen, J., Wang, N., Corbett, K. S., Wrapp, D., Kirchdoerfer, R. N., Turner, H. L., Cottrell, C. A., Becker, M. M., Wang, L., Shi, W., Kong, W.-P., Andres, E. L., Kettenbach, A. N., Denison, M. R., Chappell, J. D., Graham, B. S., Ward, A. B., & McLellan, J. S.
- Affiliations
- Scripps Research Institute (US)
- Dartmouth College (US)
- National Institute of Allergy and Infectious Diseases (US)
- Vanderbilt University Medical Center (US)
- Vanderbilt University (US)
- Corresponding author
- Pallesen, Jesper
- Wang, Nianshuang
- Corbett, Kizzmekia S.
- Ward, Andrew B.
- McLellan, Jason S.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-08-14
- Volume
- 114
- Issue
- 35
- Pages
- E7348-E7357
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5584442
- OpenAlex
- W2750464792
- Cited by
- 1,073
- References
- 89
- Citations by year
- 2026: 48 · 2025: 75 · 2024: 98 · 2023: 127 · 2022: 174 · 2021: 275 · 2020: 220 · 2019: 31 · 2018: 17 · 2017: 6
- FWCI
- 57.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI127521)
- HHS | NIH | National Institute of General Medical Sciences (P20GM113132)
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI005125)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- MERS-CoV, spike protein, structure-based vaccine design, neutralizing antibodies, receptor binding domain, receptor recognition, membrane fusion mechanism, coronavirus vaccines
- MeSH terms
- Animals, Antibodies, Viral, Coronaviridae, Humans, Immunoglobulin G, Mice, Inbred BALB C, Protein Binding, Protein Conformation, Receptors, Virus, Structure-Activity Relationship, Vaccination, Viral Vaccines, Coronavirus Infections, Crystallography, X-Ray, Immunity, Humoral, Antibodies, Neutralizing, Spike Glycoprotein, Coronavirus, Middle East Respiratory Syndrome Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
